공지사항

Stomach Cancer Lawsuit Settlement

Mass tort cases typically require large sums of cash for pain and suffering. You could be entitled lost wages if cancer prevents you from working.

A lawsuit is in the process against the defendants, but no settlements of any kind are made public. The defendants still claim that their inhibitors of proton pump are secure, despite extensive research to prove the opposite.

Nexium

Nexium is a well-known heartburn medication. It is available for purchase over-the-counter or on prescription. It is part of a class known as proton-pump inhibitors. It is used to treat stomach ulcers, stomach cancer railroad cancer settlements acid reflux and esophageal ulcers. Nexium is manufactured by AstraZeneca and generates more than $6 billion in annual sales for the company. It has been a top-selling drug in the United States since its introduction in 2001.

Lawsuits assert that AstraZeneca failed to put adequate warnings on the drug's packaging about its most dangerous adverse side effects. The lawsuits accuse AstraZeneca of company of putting profits before consumer safety.

One of the side consequences of this medication is acute interstitial kidney damage. This is known as acute interstitial necritis. This condition can result in a buildup of body toxins in the blood. This can lead to kidney failure, which requires lifelong dialysis or even the need for a kidney transplant.

Another issue is the greater chance of stomach cancer for patients who take Nexium. According to studies published by the Gut medical journal in 2010, long-term PPI use increases the risk of gastric carcinoma by up to threefold. They can also cause an infection by a bacterium known as H. pylori. Saiontz & Kirk lawyers are studying potential Nexium cases from people who have suffered these serious side effects. They are also studying claims against the makers Prilosec Prevacid and Protonix.

Zantac

Zantac is the most well-known medicine to treat heartburn and acid regurgitation. The drug was released by GlaxoSmithKline in 1981 and soon became the world's most-loved prescription and over the counter heartburn medication. Zantac is now linked to an unforeseen risk that could put your life in danger. According to lawsuits, certain types of Zantac can be contaminated with the cancer-causing substance N-nitrosodimethylamine or NDMA.

NDMA is useful in some circumstances, such as rocket fuel. However it is classified by the U.S. Food and Drug Administration and the Environmental Protection Agency and the World Health Organization as a carcinogen. The FDA has discovered that ranitidine which is the main ingredient in Zantac, metabolizes into NDMA when it enters the body.

Zantac lawsuits have been filed by thousands of patients who have developed cancer or other serious health issues after taking the drug. The people who qualify could be able to recover the cost of their past and future medical expenses such as lost wages and other damages. The amount a victim is entitled to will depend on the degree of their injuries and lawyers will consider the various ways the illness has affected each person's life. For instance, people with terminal illnesses or stage four cancers will receive higher settlements than patients in recovery.

PPIs

PPIs reduce the amount of stomach acid. They can be used in conjunction with antibiotics to treat Stomach cancer railroad cancer settlements ulcers caused due to the bacteria Helicobacter pylori. Additionally they can be taken to treat symptoms of the gastrointestinal reflux disease (GORD) such as heartburn and regurgitation. They also help in the long term to prevent recurrences of ulcers caused by NSAIDs or aspirin.

At one time, there were fears that by dramatically reducing stomach acid levels, PPIs could lead to serious infections and a poor absorption of minerals and vitamins, such as iron and vitamin B12. These fears have been dispelled by research.

Although the possibility of side effects is not that common It is crucial to tell your doctor about any medication you're taking, including blood thinners such as warfarin and clopidogrel (Plavix). It is also recommended to discuss with your pharmacist about the appropriate use of PPIs.

Numerous studies have highlighted a range of risks associated with long-term PPI therapy for a variety of reasons, including C. difficile infection (CDI) renal impairment and/or osteodystrophy of the kidney, hip fracture and interactions with anti-platelet medications, Stomach cancer railroad cancer settlements small intestinal bacterial overgrowth, and micronutrient deficiencies (particularly magnesium and vitamin B12). PPIs should not be used in a way that is harmful, particularly for patients who are elderly and/or taking multiple medications. The principle of "first do no harm" is a guiding one.